| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Sertex-Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.360 | 18.172 | 17.865 | 17.537 | 17.197 | 16.871 | 16.497 | 11.376 | 11.341 | - |
| Current Assets | 97.866 | 96.868 | 95.229 | 93.481 | 91.671 | 89.933 | 87.939 | 88.064 | 87.797 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 90.159 | 89.239 | 87.729 | 86.119 | 84.451 | 82.850 | 81.013 | 81.264 | 81.018 | - |
| Cash | 7.708 | 7.629 | 7.500 | 7.362 | 7.220 | 7.083 | 6.926 | 6.800 | 6.780 | - |
| Shareholders Funds | 89.594 | 88.680 | 87.180 | 85.580 | 83.923 | 82.332 | 80.506 | 75.948 | 75.718 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 26.632 | 26.360 | 25.914 | 25.438 | 24.946 | 24.473 | 23.930 | 23.492 | 23.421 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Sertex-Bio S.r.l.